Piper Jaffray analyst Sarah James says Centene (CNC) yesterday received an intent to award in Iowa, a $1.5B, 600,000 member Medicaid contract currently held by UnitedHealth (UNH) and Anthem (ANTM). While Iowa insurers have faced issues with rates in the past, the state has taken steps to return the contract to profitability, James tells investors in a research note. She estimates Centene could add up to 100,000 members in Iowa, generating $250M in revenue and 2c of earnings per share, with the contract set to begin July 1, 2019. The analyst keeps an Overweight rating on the shares with a $134 price target.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here